Solid Dose Manufacturing

INSIGHTS ON SOLID DOSE MANUFACTURING

Enabling Flexibility And Scientific Innovation In OSD Development
How one clinical-stage CNS biotech navigated early formulation complexity, shifting pipeline priorities, and scalable manufacturing demands through a strategic CDMO partnership.
Optimising Solubility: Selecting The Right Technology For Early Drug Development
Discover how selecting the right solubility‑enhancing technology improves early exposure, supports flexible dosing, and lays a strong foundation for downstream oral drug development.
Modeling Polymer Interactions To Improve Amorphous Solid Dispersion Stability
Molecular dynamics modeling revealed how hydrogen bonding between PVP and Eudragit drives stable amorphous solid dispersion formation, cutting formulation screening time significantly.
Predicting Softgel Stability And Shelf Life Using Accelerated Modeling
Predict ibuprofen softgel shelf life in 21 days instead of years. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before long-term studies concluded.

Achieving Manufacturing Efficiency In OSD Manufacturing
10/16/2024

Gain expert insight into the importance of instrumented tablet presses in assessing formulation properties, the role of tablet cup configurations, and scalability parameters for successful product transfer.
5 Hidden Risks In Early-Phase OSD Formulation Development
8/31/2026

Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.
Contract Pharma 2026: Mikart On CDMO Collaboration
4/30/2026

An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.
How To Fast-Track Your Oral Solid Dose To Phase 1
2/17/2026

A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster.
High Potency APIs And The Evolving Demands Of Drug Development
4/13/2026

See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.

Used Shionogi Qualicaps Pharmaceutical Capsule Filling Machine

Used Shionogi Qualicaps quali-fill capsule filling machine, serial# 96-F40.
Single-Station Hydraulic Pharmaceutical Tablet Press: NP-P20A

Natoli Engineering’s NP-P20A single-station hydraulic tablet press is a favorite for the production of injectable micropellets and for marginal formulations requiring deep-fill. The NP-P20A meets the FDA’s requirements for batch reporting and secure data management under CFR 21 Part 11 compliance.
Production-Scale Pharmaceutical Filling Systems

Dec‘s philosophy is to develop customer-specific modules and equipment. Starting with agreed project scope, intensive brainstorm sessions, strong design processes and (customer) reviews, the aim is to deliver an innovative filling solution. During the concept development, risk analysis is an important tool in the decision-making process.
Closed Pharmaceutical Restricted Access Barrier System (RABS) From Franz Ziel

Closed RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved through a barrier (cRABS housing with gloves) between the operator and the product.
Discovery Hybrid Rheometers: Temperature Systems And Accessories

Explore a wide variety of DHR temperature systems and accessories, designed for superior performance and ease-of-use.